Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. April 2026 22:24 ET | Quelle: Pepeto

New Crypto Pepeto DeFi Exchange Update While Dogecoin Price Holds at $0.09 and Shiba Inu Eyes Recovery

Dubai, UAE, April 12, 2026 (GLOBE NEWSWIRE) -- Pepeto just announced a full DeFi exchange suite during its presale, something no meme coin in history has done before listing, and the traction is...
12. April 2026 20:25 ET | Quelle: Pepeto

Crypto News: Pepeto Announces Fast Stage Sell Out While BNB Price Prediction Targets $900 and Whale Wallets Quietly Move Elsewhere

Dubai, UAE, April 12, 2026 (GLOBE NEWSWIRE) -- Pepeto's latest presale stage sold out faster than any round before it, pushing the raise above $8,971, and the crypto news connecting this project...
12. April 2026 20:24 ET | Quelle: Pepeto

Ethereum Based Crypto Pepeto Closes In on Binance Listing While Cardano Price Prediction Builds Strong Momentum

Dubai, UAE, April 12, 2026 (GLOBE NEWSWIRE) -- Ethereum based crypto Pepeto entered its final presale stretch before the Binance listing, and the raise turned into the quickest-selling presale of...
12. April 2026 19:43 ET | Quelle: Pepeto

Crypto News: Pepeto Announces Investments Growth While Bitcoin Price Prediction Moves After Iran Talks Collapse

Dubai, UAE, April 12, 2026 (GLOBE NEWSWIRE) -- Crypto news around Pepeto is accelerating faster than any presale this cycle. Whale wallets keep entering at record pace, daily buys from large holders...
12. April 2026 19:30 ET | Quelle: Nxera Pharma

Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia

NBI-1117570 is an investigational oral, dual muscarinic M1/M4 selective receptor agonist discovered by Nxera advancing through clinical development under a multi-program collaboration with...
12. April 2026 19:16 ET | Quelle: The Rosen Law Firm PA

APO DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Apollo Global Management, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - APO

NEW YORK, April 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apollo Global Management, Inc. (NYSE: APO) between May 10,...
12. April 2026 18:03 ET | Quelle: Pepeto

New Crypto: Pepeto Announces $8.969M Raised While Ethereum Price Prediction Could Reach $15,000 by Year End

Dubai, UAE, April 12, 2026 (GLOBE NEWSWIRE) -- New crypto Pepeto just crossed $8,969,618, the fastest growing presale of this entire cycle. That number is not just momentum, it is proof of how much...
12. April 2026 11:56 ET | Quelle: The Rosen Law Firm PA

NAVN FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Navan, Inc. Investors to Secure Counsel Before Important April 24 Deadline in Securities Class Action – NAVN

NEW YORK, April 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Navan, Inc. (NASDAQ: NAVN) pursuant and/or traceable to...
12. April 2026 11:09 ET | Quelle: The Rosen Law Firm PA

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Super Micro Computer, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SMCI

NEW YORK, April 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Super Micro Computer, Inc. (NASDAQ: SMCI) between April 30,...
12. April 2026 10:57 ET | Quelle: Pepeto

Crypto News: Pepeto Launch Update While Markets Ask If XRP Price Prediction Can Ever Reach $10

Dubai, UAE, April 12, 2026 (GLOBE NEWSWIRE) -- Pepeto is on the edge of a full launch, with a preview page now live on CoinMarketCap and multiple reports confirming a Binance listing is locked in...

Vorherige Seite

Nächste Seite